United States set
language
Menu Shopping cart $0 Search
Manufactured by BioVendor

Human TARC (CCL17) ELISA

  • Regulatory status:RUO
  • Type:Sandwich ELISA
  • Other names:Thymus and activation-regulated chemokine, CCL17, CC motif chemokine ligand 17, ABCD-2, SCYA17
  • Species:Human
Cat. No. Size Price


New RBL028R 96 wells (1 kit)
PubMed Product Details
Technical Data

Type

Sandwich ELISA

Applications

Serum

Sample Requirements

35 µl/well

Shipping

Shipped on blue ice packs. Upon receipt, store the product at the temperature recommended below.

Storage/Expiration

Store the complete kit at 2–8°C. Under these conditions, all components are stable until the expiration date (see label on the box).

Calibration Range

2000 - 20 pg/ml

Limit of Detection

4 pg/ml

Intra-assay (Within-Run)

CV =3,5%

Inter-assay (Run-to-Run)

CV =6,1%

Spiking Recovery

92%

Dilution Linearity

83%

Summary

Features

  • It is intended for research use only
  • The total assay time is less than 3 hours
  • The kit measures specifically human TARC
  • Assay format is 96 wells
  • Standard is a recombinant protein
  • Components of the kit are provided ready to use, concentrated or dried

Research topic

Autoimmunity, Oncology

Summary

TARC (thymus and activation-regulated chemokine), also known as C-C motif chemokine ligand 17 (CCL17), is expressed in the thymus and is produced by dendritic cells, endothelial cells, keratinocytes, and fibroblasts. TARC has affinity as a ligand for the C-C chemokine receptors CCR4 and CCR8 inducing Th2-dominant inflammatory reactions. TARC has an important role in allergic diseases such as atopic dermatitis and bronchial asthma. High serum concentrations of TARC are observed in patients with atopic dermatitis, and its concentration reflects the disease activity. The concentration of TARC is also reported to be elevated in sputum of patients with bronchial asthma, and TARC may have potential as a therapeutic target. In clinical practice, TARC is useful also in selection of patients requiring new therapies of atopic dermatitis or asthma.

Related Products Docs
Subscribe to Our Newsletter! Discover News from
BioVendor R&D
Subscribe Now
Subscribe to Our Newsletter! Discover News from
BioVendor R&D
Subscribe Now
zavřít